Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Intellia Therapeutics Inc. (NTLA)

14.42   -0.39 (-2.63%) 05-23 16:00
Open: 14.65 Pre. Close: 14.81
High: 14.73 Low: 14.15
Volume: 617,585 Market Cap: 659M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.758 - 14.842 14.842 - 14.933
Low: 13.919 - 14.01 14.01 - 14.109
Close: 14.246 - 14.406 14.406 - 14.581

Technical analysis

as of: 2019-05-23 4:27:13 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 18.97     One year: 20.49
Support: Support1: 14.15    Support2: 11.77
Resistance: Resistance1: 16.25    Resistance2: 17.54
Pivot: 15.74
Moving Average: MA(5): 15.11     MA(20): 15.71
MA(100): 15.48     MA(250): 20.87
MACD: MACD(12,26): -0.40     Signal(9): -0.29
Stochastic oscillator: %K(14,3): 24.45     %D(3): 30.22
RSI: RSI(14): 40.73
52-week: High: 32.95  Low: 11.03  Change(%): -44.2
Average Vol(K): 3-Month: 56429  10-Days: 45138

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
NTLA has closed above bottom band by 4.9%. Bollinger Bands are 0.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 02 May 2019 19:09:43 Z
Intellia Therapeutics, Inc. (NTLA) Q1 2019 Earnings Call Transcript

Thu, 02 May 2019 15:21:20 Z
Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Lags Revenue Estimates

Wed, 17 Apr 2019 13:09:41 Z
Vertex, CRISPR's Gene Editing Drug Gets FDA's Fast Track Tag

Thu, 07 Mar 2019 21:09:40 Z
5 Top Gene-Editing Stocks for 2019

Tue, 26 Feb 2019 17:06:41 Z
CRISPR Therapeutics Up as Dosing Starts in Thalassemia Study

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 45.71
Shares Float (M) 44.15
% Held by Insiders
% Held by Institutions 97.40
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.990
EPS Est. Current Year -1.780
EPS Est. Next Year -2.060
EPS Est. Next Quarter -0.460
Forward EPS -2.660
Book Value (p.s.) 2.790
PEG Ratio -0.20
Profit Margin
Operating Margin -276.21
Return on Assets (ttm) -24.4
Return on Equity (ttm) -30.7
Qtrly Rev. Growth 39.7
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -64.94
Levered Free Cash Flow (M) -29.31

Stock Valuations

P/E -7.25
P/E Growth Ratio -0.03
P/BV 5.17
P/S 867287168.00
P/CF -10.15

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.